The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and Meta-Regression
Pooled result · Change in HbA1cResult — go to the resultMD −0.415 % 95% CI −0.482% to −0.348%Authors' conclusion
In conclusion, telemedicine may serve as a valuable supplement to usual care for patients with T2D. The inclusion of a telemonitoring component seems to increase the effect of telemedicine.
Study context
- Population
- Adults (≥18 years) with T2D in telemedicine randomized controlled trials (RCTs); PubMed, EMBASE and CENTRAL searched October 14, 2020246 papers
- Comparison
- Telemedicine solutions vs any comparator without telemedicine
- Outcome
- Change in HbA1c (%)
Methodological detailsPRISMA, revised Cochrane risk-of-bias tool, Grading of Recommendations, Assessment, Development and Evaluations (GRADE)
- PRISMA
- Revised Cochrane risk-of-bias tool
- GRADE
Pooled result
Change in HbA1c
MD
−0.415 %
95% CI −0.482% to −0.348%
Telemedicinevs No telemedicine
MD −0.415 % (95% CI −0.482% to −0.348%)
As reported in the abstract
- Heterogeneity (I2)
- 93.05%
Further pooled results
Meta-regression: monitoring component
- A monitoring component gave rise to higher effects of telemedicine
Original publication
The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and Meta-Regression. J Diabetes Sci Technol. Published 26 December 2021. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →